| Identification | More | [Name]
5,6-DIHYDROURACIL | [CAS]
504-07-4 | [Synonyms]
5,6-DIHYDRO-2,4-DIHYDROXYPYRIMIDINE
5,6-DIHYDROURACIL
DIHYDRO-2,4(1H,3H)-PYRIMIDINEDIONE
DIHYDROURACIL
TIMTEC-BB SBB007702
2,4(1H,3H)-Pyrimidinedione, dihydro-
3h)-pyrimidinedione,dihydro-4(1h
Dihydro-pyrimidine-2,4-dione
Hydrouracil
DIHYDROURACIL CRYSTALLINE
5,6-Dihydrouracil,99%
5,6-Dihydrouracil-UL-13C4, UL-15N2
1,3-diazinane-2,4-dione
5,6-Dihydrouracil, HPLC 98%
DIHYDROPYRIMIDINE-2,4(1H,3H)-DIONE
5,6-DIHYDROURACIL 98%
5,6-Dihydropyrimidine-2,4(1H,3H)-dione
Hexahydropyrimidine-2,4-dione | [EINECS(EC#)]
207-982-1 | [Molecular Formula]
C4H6N2O2 | [MDL Number]
MFCD00006029 | [Molecular Weight]
114.1 | [MOL File]
504-07-4.mol |
| Chemical Properties | Back Directory | [Appearance]
white to light beige crystalline powder | [Melting point ]
279-281 °C (lit.) | [Boiling point ]
213.59°C (rough estimate) | [density ]
1.3565 (rough estimate) | [refractive index ]
1.4487 (estimate) | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
Soluble in Sodium Hydroxide. | [form ]
Solid | [pka]
12.10±0.20(Predicted) | [color ]
White to Light Beige | [BRN ]
112496 | [InChI]
InChI=1S/C4H6N2O2/c7-3-1-2-5-4(8)6-3/h1-2H2,(H2,5,6,7,8) | [InChIKey]
OIVLITBTBDPEFK-UHFFFAOYSA-N | [SMILES]
C1(=O)NCCC(=O)N1 | [CAS DataBase Reference]
504-07-4(CAS DataBase Reference) | [EPA Substance Registry System]
2,4(1H,3H)-Pyrimidinedione, dihydro- (504-07-4) |
| Hazard Information | Back Directory | [Chemical Properties]
white to light beige crystalline powder | [Uses]
Impurity of Uracil. | [Definition]
ChEBI: 5,6-dihydrouracil is a pyrimidine obtained by formal addition of hydrogen across the 5,6-position of uracil. It has a role as a metabolite, a human metabolite, an Escherichia coli metabolite and a mouse metabolite. It is functionally related to a uracil. | [General Description]
Dihydrouracil (DiHU) is a minor base found in transfer ribonucleic acid (tRNA). It is similar to uracil with the only exception that the C5-C6 bond is saturated. It crystallized in the monoclinic system with space group P21/C. Its crystalline structure has been analyzed. Its generation from L-cysteine and uracil via photochemical addition has been described. | [storage]
Store at -20°C |
|
|